DFE Pharma

Abstract Purposes The tabletability flip phenomenon (TFP), where an active pharmaceutical ingredient (API) with poorer tabletability exhibits better tabletability when...

We previously demonstrated the use of near-infrared (NIR) imaging to evaluate differences in disintegration for various capsule formulations after oral...

Abstract Dry Powder Inhaler (DPI) formulations generally consist of drug particles with a size between 1 and 5 µm, ideal for...

Abstract Co-milling with excipients offers an effective solvent-free strategy to enhance the dissolution of drugs in the pharmaceutical industry. Nonetheless,...

Abstract Introduction: Formulation research benefits from high-throughput excipient screening methods, considering the ever-growing excipient space. We investigate the use of 384-well...

Abstract Moisture is a critical external factor affecting the powder behaviour. This work focused on the effect of moisture on...

Abstract Magnesium stearate (MgSt) has been used as a force control agent (FCA) to enhance the aerosol performance of carrier-based...

Abstract Roller compaction is often utilized as the first step to improve flow properties and homogeneity of pharmaceutical mixtures. Since...

Abstract The development of dry powder inhalers (DPIs) for pulmonary drug delivery is complex, requiring optimization of variable factors to...

Frankfurt, Germany, 02 October, 2024 The future of excipients is here: Meet DFE Pharma at CPHI DFE Pharma invites you to...